Showing results (11-20 of 215) with videos related to
Sort By:
Pageof 22
Current Cancer Drug Targets|February 10, 2009
Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapyPaul R Andreassen, Keqin RenMutation Research|September 24, 2009
Fanconi anemia proteins and endogenous stressesQishen Pang, Paul R AndreassenCell Cycle (Georgetown, Tex.)|February 7, 2015
FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complexMaya Raghunandan, Indrajit Chaudhury, Stephanie L Kelich, et al.Cell Cycle (Georgetown, Tex.)|December 17, 2005
Assessing the link between BACH1 and BRCA1 in the FA pathwaySharon B Cantor, Paul R AndreassenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck CancersAnne J Lombardi, Elizabeth E Hoskins, Grant D Foglesong, et al.Journal of Medical Genetics|September 4, 2017
DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessmentAmanda Ewart Toland, Paul R AndreassenJournal of Virology|September 5, 2002
Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsidsMartin Heinkelein, Cordula Leurs, Matthias Rammling, et al.Molecular Pharmacology|July 10, 2012
CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variantMariko Nakano, Edward J Kelly, Constanze Wiek, et al.Biological Chemistry|September 16, 2006
Impact of the arylhydrocarbon receptor on eugenol- and isoeugenol-induced cell cycle arrest in human immortalized keratinocytes (HaCaT)Michaela Kalmes, Andrea Neumeyer, Paola Rio, et al.Frontiers in Immunology|February 15, 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" ImmunotherapyKeven Hoerster, Markus Uhrberg, Constanze Wiek, et al.Pageof 22